A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
2020 · Annals of Oncology · 79 citations
https://doi.org/10.1016/j.annonc.2020.10.601
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
523
Citations
11
h-index
12
i10-index
Charles Vanbrugghe is an academic researcher from Hôpital de la Timone. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Hepatocellular Carcinoma Treatment and Prognosis & Pancreatitis Pathology and Treatment. The author has an h-index of 11, co-authored 35 publications.
ORCID: 0000-0002-9285-7268https://doi.org/10.1016/j.annonc.2020.10.601
https://doi.org/10.1016/j.ebiom.2020.102858
Click to start Chat